Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1464-410X.2007.06876.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Commercial Prices and Care for Medicare Beneficiaries With Prostate Cancer.
Urology
November 2024
Department of Urology, Massachusetts General Hospital, Boston, MA.
Objective: To examine the relationship between market dynamics, in the form of commercial prices paid to urologists, and utilization of services, as measured by Medicare spending, in men with newly diagnosed prostate cancer.
Methods: We performed a retrospective national cohort study of Medicare beneficiaries with newly diagnosed prostate cancer between 2014 and 2019, with follow-up through 2020. The primary exposure was the commercial price index (ie, the ratio of commercial prices to Medicare prices for a common set of services performed by urologists).
Updates in digital shared care: Launching into the 21st century.
Aust J Gen Pract
November 2024
MBBS, PhD, FRACS, Head of Unit, Department of Urology, Western Health, Melbourne, Vic; Professor of Surgery, Department of Surgery, University of Melbourne, Melbourne, Vic; Consultant Urologist, Department of Urology, Royal Melbourne Hospital, Melbourne, Vic; Victorian Comprehensive Cancer Centre (VCCC) Alliance Research and Education Lead @ Genitourinary Cancer, Division of Surgery, VCCC, Melbourne, Vic.
Background: The recent Intergenerational Report (2023) highlighted that the Australian healthcare system will face increasing economic and logistical challenges, with projected growth in health spending due to an ageing population and an increasing number of chronic diseases. Shared care, a model emphasising collaboration between nursing and allied health, general practice and specialist care providers, has emerged as one solution.
Objective: This paper explores the contemporary shared care landscape in Australia, highlighting the digital transformation of healthcare, the adoption of eHealth technologies, and their impact on improving patient care coordination.
Clinical decision making in prostate cancer care-evaluation of EAU-guidelines use and novel decision support software.
Sci Rep
August 2024
Department of Urology, University Hospital Basel, Basel, Switzerland.
Keeping up to date with the latest clinical advances in prostate cancer can be challenging. We investigated the impact of guideline use on quality of treatment decisions as well as the impact of a novel, CE-certified clinical decision support tool (Siemens AIPC software) on the amount of time clinicians spend on decision-making in a multicenter setting. Ten urologists assessed ten clinical cases (screening and localized prostate cancer) in three settings: without support, using a digital version of the EAU guidelines, and with the AIPC tool, resulting in 300 clinical decisions.
View Article and Find Full Text PDFVariation in content discussed by specialty in consultations for clinically localized prostate cancer.
Urol Oncol
September 2024
Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Cedars-Sinai Center for Outcomes. Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address:
Introduction: Multidisciplinary consultations improve decisional conflict and guideline-concordant treatment for men with prostate cancer (PC), but differences in the content discussed by specialty during consultations are unknown.
Methods: We audiorecorded and transcribed 50 treatment consultations for localized PC across a multidisciplinary sample of urologists, radiation oncologists, and medical oncologists. Conversation was coded for narrative content using an open coding approach, grouping similar topics into major content areas.
Online Tools to Decrease Out-of-Pocket Prescription Costs for Patients: A Practical Guide for Urologists.
Urol Pract
May 2024
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Introduction: Patients who seek urologic care have recently reported a high degree of financial toxicity from prescription medications, including management for nephrolithiasis, urinary incontinence, and urological oncology. Estimating out-of-pocket costs can be challenging for urologists in the US because of variable insurance coverage, local pharmacy distributions, and complicated prescription pricing schemes. This article discusses resources that urologists can adopt into their practice and share with patients to help lower out-of-pocket spending for prescription medications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!